Pancreatitis: There have been reports of acute pancreatitis (inflammation of the pancreas) associated with GLP-1 receptor agonists
PA requests for non-preferred cytokine and CAM antagonist drugs used to treat GPP may be submitted on the Portal, by fax, or by mail (but not using the STAT-PA system)
Nevertheless, the need for larger trials that are streamlined towards examining its therapeutic abilities for cardiovascular illnesses, exists
The transition is relatively gentle because only gastric emptying and appetite regulation are changing
Submit a New Drug Application (NDA): Eli Lilly is expected to submit a New Drug Application (NDA) to the FDA for obesity if the Phase III program is successful
However, recent guidelines now recommend a more flexible approach, especially for patients with cardiovascular disease or high-risk profiles